Clinical TrialsSearch results
Number of results: 67288
Completed
- A research study of how the medicine NNC0480-0389 taken with semaglutide works in the body of healthy Japanese men
- type 2 diabetes
- Hashida Masahiro
- 2021-05-11
Completed
- A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
- Lupus Erythematosus, Systemic
- Yokoyama Yoshinari
- 2023-05-26
Completed
- A research study to see how well the new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar level in people with type 2 diabetes compared to weekly insulin icodec (COMBINE1)
- type 2 diabetes
- Takizaki Hiroshi
- 2022-06-18
Completed
- A research study to see how well the new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar level in people with type 2 diabetes compared to weekly semaglutide (COMBINE 2)
- type 2 diabetes
- Miwa Hirotaka
- 2022-06-10
Completed
- A Retrospective Observational Study in the Expanded Access Program of Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer (BEACON EAP Follow-up Study )
- BRAF V600E-mutant metastatic colorectal cancer
- Daisuke Kotani
- 2022-07-26
Completed
- A S ingle Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)
- Coronavirus Disease (COVID-19)
- Kuriyama Kenji
- 2022-03-30
Completed
- A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines
- Chronic Spontaneous Urticaria
- Maruyama Hideki
- 2021-12-26
Completed
- A Safety Study of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells Therapy in Refractory Skin Ulcers
- Refractory Cutaneous Ulcers
- Ichinohe Tatsuo
- 2021-06-23
Completed
- A single and multiple dose study of M127101 in healthy subjects
- Nasal polyp accompanies eosinophilic chronic rhinosinusitis
- Tomoyuki Nishiura
- 2023-06-07
Completed
- A single dose study in healthy Japanese participants to evaluate the safety and pharmacokinetics of otilimab.
- Rheumatoid Arthritis
- Yamada Masanori
- 2022-03-09